This publication was developed with the support of Boehringer Ingelheim Pharmaceuticals, Inc.
Enhancing Chronic Kidney Disease Treatment With Guideline-Directed Medical Therapies Through Electronic Alert Systems and Integrated Care Management Initiatives
Advertisement
Advertisement
Trending on AJMC
1
5 FAQs: Ebola Outbreaks and the Challenge of Public Trust
2
MRD-Guided CLL Treatment Duration: Personalization or Malpractice?
3
Incretin Innovation, Metabolic Liver Disease, and Cardiovascular Risk Reduction Dominate ADA 2026
4
Blinatumomab Improves Outcomes, Toxicity in High-Risk Pediatric ALL: Martin Schrappe, MD, PhD
5